Skip to main content
. 2021 Feb 23;2(1):iqab006. doi: 10.1093/oxfimm/iqab006

Figure 1:

Figure 1:

Kinetics of SARS-CoV-2-specific T cell and antibody response in COVID-19 patients with mild and severe disease.